Literature DB >> 32732929

A comparative study of RTK gene status between primary tumors, lymph-node metastases, and Krukenberg tumors.

Guoping Ren1,2, Xiaoling Wang3, Bo Wang4, Qiusu Tang4,5, Liming Xu4,5, Xiaodong Teng4, Wei Ding4.   

Abstract

Krukenberg tumor (KT) refers to a rare ovarian tumor that has metastasized from a primary site. Patients with KTs have a poorer prognosis and worse survival. Thus far, little is known about the frequency of receptor tyrosine kinase (RTK) gene amplification and the concordance of gene amplification between primary tumors, lymph-node metastases, and KTs. Herein, 50 paired samples, including primary cancers, metastatic lymph nodes, and KTs were collected, and RTK gene amplification was tested by fluorescence in situ hybridization (FISH). There were four cases positive for human epidermal growth factor receptor type 2 (HER2) amplification, all of which showed conversion of HER2 status between different lesions. Of the two cases with c-mesenchymal-epithelial transition (c-MET) amplification, the primary tumors and lymph nodes were negative while the right involved ovaries were positive. Inconsistent fibroblast growth factor receptor 2 (FGFR2) status in different lesions was observed in three of the six FGFR2-amplified cases. Co-amplification of RTK genes was identified in only one patient for primary cancer and two for KTs. Collectively, there were 46, 48, 50, and 44 cases negative for HER2, c-MET, EGFR, and FGFR2 amplification in all lesions, respectively. There was no significant difference in overall survival between KTs of gastric origin and colorectal origin. However, of all synchronous cancers, KTs of colorectal origin had a better prognosis than those of gastric origin. In conclusion, the positive rate of RTK gene amplification in KTs was low. Intratumoral heterogeneity was frequent in KTs with RTK gene amplification. A mutually exclusive pattern of RTK gene amplification was dominant in primary cancers, lymph-node metastases, and KTs. There was no survival difference between KTs of gastric origin and colorectal origin. However, of all synchronous cancers, KTs of colorectal origin had a better prognosis than those of gastric origin.

Entities:  

Year:  2020        PMID: 32732929     DOI: 10.1038/s41379-020-0636-7

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  3 in total

1.  Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha.

Authors:  Felix Berlth; Stefan P Mönig; Hans A Schlösser; Martin Maus; Christoph T H Baltin; Alexander Urbanski; Uta Drebber; Elfriede Bollschweiler; Arnulf H Hölscher; Hakan Alakus
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

2.  Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance.

Authors:  Hirokazu Shoji; Yasuhide Yamada; Natsuko Okita; Atsuo Takashima; Yoshitaka Honma; Satoru Iwasa; Ken Kato; Tetsuya Hamaguchi; Yasuhiro Shimada
Journal:  Anticancer Res       Date:  2015-09       Impact factor: 2.480

3.  Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer.

Authors:  Phillip Stahl; Carsten Seeschaaf; Patrick Lebok; Asad Kutup; Maximillian Bockhorn; Jakob R Izbicki; Carsten Bokemeyer; Ronald Simon; Guido Sauter; Andreas H Marx
Journal:  BMC Gastroenterol       Date:  2015-02-05       Impact factor: 3.067

  3 in total
  1 in total

1.  A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin.

Authors:  Xiaolin Lin; Ting Han; Meng Zhuo; Tengfei Liu; Zebing Liu; Dongxi Xiang; Hong Li; Xiuying Xiao
Journal:  J Gastrointest Oncol       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.